In November 2022, the Health Commission of [[Lanzhou]] announced that staffers with Lanzhou Nucleus Huaxi Laboratory, Nucleus Gene’s local subsidiary, wrongfully counted certain abnormal test results in a tally of negative results and uploaded them into the working system.<ref>{{Cite web |date=2022-11-28 |title=China’s Nucleus Huaxi Lab Is Exposed for Logging Incorrect Covid-19 Test Results |url=https://www.yicaiglobal.com/news/china-nucleus-huaxi-lab-is-exposed-for-logging-incorrect-covid-19-test-results |url-status=live |archive-url=https://archive.ph/Niiug |archive-date=2024-10-17 |access-date=2024-09-22 |website=www.yicaiglobal.com |language=en}}</ref> The laboratory was newly established in August. In the Health Commission’s statement, the laboratory was reprimanded for lax management of its staffers and disregard for the country’s anti-epidemic effort.<ref name=”:5″ /> Nucleus Gene’s laboratories in [[Xingtai]], [[Jinan]], [[Changsha]], and Shenzhen have been hit with local fines since 2020, for issues related to testing results or other operational violations.<ref name=”:2″ />
In November 2022, the Health Commission of [[Lanzhou]] announced that staffers with Lanzhou Nucleus Huaxi Laboratory, Nucleus Gene’s local subsidiary, wrongfully counted certain abnormal test results in a tally of negative results and uploaded them into the working system.<ref>{{Cite web |date=2022-11-28 |title=China’s Nucleus Huaxi Lab Is Exposed for Logging Incorrect Covid-19 Test Results |url=https://www.yicaiglobal.com/news/china-nucleus-huaxi-lab-is-exposed-for-logging-incorrect-covid-19-test-results |url-status=live |archive-url=https://archive.ph/Niiug |archive-date=2024-10-17 |access-date=2024-09-22 |website=www.yicaiglobal.com |language=en}}</ref> The laboratory was newly established in August. In the Health Commission’s statement, the laboratory was reprimanded for lax management of its staffers and disregard for the country’s anti-epidemic effort.<ref name=”:5″ /> Nucleus Gene’s laboratories in [[Xingtai]], [[Jinan]], [[Changsha]], and Shenzhen have been hit with local fines since 2020, for issues related to testing results or other operational violations.<ref name=”:2″ />
Chinese government adopted [[zero-COVID]] strategy which included frequent PCR testing and srtict quarantine policies, and invested huge amounts of public health resources for it.<ref name=”JTD-Zanin-2020″>{{cite journal |last1=Zanin |first1=Mark |last2=Xiao |first2=Cheng |last3=Liang |first3=Tingting |last4=Ling |first4=Shiman |last5=Zhao |first5=Fengming |last6=Huang |first6=Zhenting |last7=Lin |first7=Fangmei |last8=Lin |first8=Xia |last9=Jiang |first9=Zhanpeng |last10=Wong |first10=Sook-San |date=August 2020 |title=The public health response to the COVID-19 outbreak in mainland China: a narrative review |journal=Journal of Thoracic Disease |volume=12 |issue=8 |pages=4434–4449 |doi=10.21037/jtd-20-2363 |pmc=7475588 |pmid=32944357 |archive-url=https://archive.ph/xjSMp |archive-date=2024-10-17 |doi-access=free}}</ref> Errors and omissions in PCR testing have led the public to question whether there is collusion between testing contractors and government officials.<ref name=”:4″ />
Chinese government adopted [[zero-COVID]] strategy which included frequent PCR testing and srtict quarantine policies, and invested huge amounts of public health resources for it.<ref name=”JTD-Zanin-2020″>{{cite journal |last1=Zanin |first1=Mark |last2=Xiao |first2=Cheng |last3=Liang |first3=Tingting |last4=Ling |first4=Shiman |last5=Zhao |first5=Fengming |last6=Huang |first6=Zhenting |last7=Lin |first7=Fangmei |last8=Lin |first8=Xia |last9=Jiang |first9=Zhanpeng |last10=Wong |first10=Sook-San |date=August 2020 |title=The public health response to the COVID-19 outbreak in mainland China: a narrative review |journal=Journal of Thoracic Disease |volume=12 |issue=8 |pages=4434–4449 |doi=10.21037/jtd-20-2363 |pmc=7475588 |pmid=32944357 |archive-url=://archive./ |archive-date=2024-10-17 |doi-access=free}}</ref> Errors and omissions in PCR testing have led the public to question whether there is collusion between testing contractors and government officials.<ref name=”:4″ />
=== Marketing hype and advertising violation ===
=== Marketing hype and advertising violation ===
Nucleus Gene Technology Co., Ltd., or Nucleus Gene Group, established in 2012 and headquartered in Shenzhen, is a Chinese enterprise engaged in the research and application of genetic testing. It is also a medical testing institution, it became a focus of attention in November 2022, due to the problematic COVID-19 PCR testing operation from one of its subsidiaries.
Nucleus Gene was co-founded by Zhang Hezi and his wife Ba Ying, both are graduates of China Medical University.[1] Zhang obtained a master’s degree in forensic science. After graduation he worked at the Shenzhen Municipal Public Security Bureau upon graduation and played a role in establishing its DNA profiling center.[1] Ba Ying worked in Shenzhen Second People’s Hospital as an attending physician after her graduation. The couple tried to start a business around the year 2000, venturing into various industries such as interior decoration, real estate, and retail.[2] In 2012, the couple founded Nucleus Gene Technology Co. in Shenzhen.[3]
In 2013, Nucleus Gene established its first medical laboratory in Shenzhen that has obtained the forensic appraisal accreditation issued by the Ministry of Justice. Since then, the company has been opening 3-4 new laboratories nationwide annually.[4]
In 2016, Nucleus Gene launched an expansion plan aiming to establish 100 state-licensed laboratories nationwide and a network of 10,000 “health centers.” These centers would offer personalized genetic testing and health consultations based on the results, as well as DNA paternity testing services.[1]
After the COVID-19 outbreak in early 2020, Nucleus Gene shifted its business focus to PCR testing services.[4] As of November 2022, the company’s official website reported that it had conducted over 700 million COVID-19 PCR tests across 45 cities for a continuous period of more than 800 days. In 2022 alone, Nucleus Gene established 16 new medical testing laboratories nationwide, primarily focusing on COVID-19 PCR testing services.[4]
In early January 2023, Nucleus Gene dissolved and closed 3 subsidiaries running testing laboratories in Dalian, Qingdao, and Quanzhou.[5]
On June 15, 2023, Nucleus Gene amended its company registration information, adding “non-residential real estate leasing” to its business scope.[6][7]
Nucleus Gene’s core businesses include forensic DNA analysis, genetic testing, medical research supporting, and personal health management solutions.[8] It has 46 subsidiaries nationwide, and 31 laboratories mainly covering provincial capital cities, as of November 2022.[9]
The company’s initial business was outsourced forensic appraisals for judicial authorities. They subsequently launched consumer-grade genetic testing services, including “talent assessments” based on genetic analysis and children’s DNA paternity testing,[8] and they recruited agents and franchisees to sell and market such services.[10]
The core of the company’s business began to shift toward COVID-19 PCR testing following the 2019 coronavirus disease outbreak.[4] During the epidemic, Nucleus Gene has won multiple government bids to provide PCR testing services for schools, government departments, and some hotels. The company also invested in the construction of testing kiosks, establishing 320 such facilities in various municipal districts of Tianjin. These kiosks offered convenient and accessible COVID-19 testing services to the public.[2]
COVID testing error
[edit]
In November 2022, the Health Commission of Lanzhou announced that staffers with Lanzhou Nucleus Huaxi Laboratory, Nucleus Gene’s local subsidiary, wrongfully counted certain abnormal test results in a tally of negative results and uploaded them into the working system.[11] The laboratory was newly established in August. In the Health Commission’s statement, the laboratory was reprimanded for lax management of its staffers and disregard for the country’s anti-epidemic effort.[9] Nucleus Gene’s laboratories in Xingtai, Jinan, Changsha, and Shenzhen have been hit with local fines since 2020, for issues related to testing results or other operational violations.[2]
Chinese government adopted zero-COVID strategy which included frequent PCR testing and srtict quarantine policies, and invested huge amounts of public health resources for it.[12] Errors and omissions in PCR testing have led the public to question whether there is collusion between testing contractors and government officials.[10]
Marketing hype and advertising violation
[edit]
In 2019, a TV crew work for a channel under Hunan Broadcasting System conducted an undercover investigation at a Nucleus Gene “Health Center” franchise in Changsha, focusing on their “talent gene assessment” service. Subsequently, the program invited experts to expose the sales representatives’ false claims about the service. Following that, the local market regulatory department launched an investigation into the company for allegedly engaging in false advertising and violating advertising regulations.[8]
- ^ a b c 每日经济新闻 (2022-11-29). “张姗姗背后的深圳核子基因：核酸检测屡出问题，全国多地招采样员，三线城市月薪可过万”. news.sina.com.cn (in Chinese). Archived from the original on 2024-10-17. Retrieved 2024-09-20.
- ^ a b c “实探”核子基因”：累计已做7亿次核酸，正准备IPO！”张核子”多年前闪现A股，市值超千万”. www.stcn.com (in Chinese). 2022-11-29. Archived from the original on 2024-10-17. Retrieved 2024-09-20.
- ^ “张姗姗背后：张核子和他的”核酸版图”“. www.eeo.com.cn (in Chinese). 2022-11-28. Archived from the original on 2024-10-17. Retrieved 2024-09-20.
- ^ a b c d “风口浪尖的核子基因：司法鉴定基因检测起家，持续扩张核酸检测业务暗藏IPO计划”. www.21jingji.com (in Chinese). 2022-11-28. Archived from the original on 2024-10-17. Retrieved 2024-09-21.
- ^ “核子基因旗下多地公司申请注销”. finance.ce.cn (in Chinese). 2023-01-11. Archived from the original on 2024-10-17. Retrieved 2024-09-21.
- ^ “核子基因今年要在四地进军房屋租赁业务？有官方作出回应”. www.yicai.com (in Chinese). 2023-07-01. Archived from the original on 2024-10-17. Retrieved 2024-09-21.
- ^ “Controversial Chinese PCR Test Giant Nucleus Gene Enters Ready Meals Business”. www.yicaiglobal.com. 2023-09-25. Archived from the original on 2024-10-17. Retrieved 2024-09-21.
- ^ a b c “核子基因的三个关键人物：张姗姗7月后才频繁担任核酸检测企业高管，张核子巴颖曾做装修工程”. www.jiemian.com (in Chinese). 2022-11-28. Archived from the original on 2024-10-17. Retrieved 2024-09-21.
- ^ a b “Shenzhen-based gene tech firm under fire after COVID-19 testing unit reprimanded for lax management”. www.globaltimes.cn. 2022-11-28. Archived from the original on 2024-10-17. Retrieved 2024-09-22.
- ^ a b “多次受罚却带病狂奔，做了7亿人次核酸的核子基因，这10年都干了些啥？”. www.yicai.com (in Chinese). 2022-11-30. Archived from the original on 2022-11-30. Retrieved 2024-09-21.
- ^ “China’s Nucleus Huaxi Lab Is Exposed for Logging Incorrect Covid-19 Test Results”. www.yicaiglobal.com. 2022-11-28. Archived from the original on 2024-10-17. Retrieved 2024-09-22.
- ^ Zanin, Mark; Xiao, Cheng; Liang, Tingting; Ling, Shiman; Zhao, Fengming; Huang, Zhenting; Lin, Fangmei; Lin, Xia; Jiang, Zhanpeng; Wong, Sook-San (August 2020). “The public health response to the COVID-19 outbreak in mainland China: a narrative review”. Journal of Thoracic Disease. 12 (8): 4434–4449. doi:10.21037/jtd-20-2363. PMC 7475588. PMID 32944357. Archived from the original on 2024-10-17.
